Research graph
References from Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics. Local targets link to admitted publications; unresolved targets remain external evidence.
Blood-brain barrier disruption increases amyloid-related pathology in TgSwDI mice
10.3390/ijms22031231 · 2021 · External reference
10.3390/pharmaceutics12010020
10.3390/pharmaceutics12010020 · External reference
10.1002/1873-3468.13967
10.1002/1873-3468.13967 · External reference
Vesicular ATP-binding cassette transporters in human disease: relevant aspects of their organization for future drug development
10.4155/fdd-2020-0025 · 2020 · External reference
The growing evidence for targeting P-glycoprotein in lysosomes to overcome resistance
10.4155/fmc-2019-0350 · 2020 · External reference
10.3390/ijms22041593
10.3390/ijms22041593 · External reference
Do ABC transporters regulate plasma membrane organization?
10.1186/s11658-020-00224-x · 2020 · External reference
Binding of Amyloid β(1–42)-Calmodulin Complexes to Plasma Membrane Lipid Rafts in Cerebellar Granule Neurons Alters Resting Cytosolic Calcium Homeostasis
10.3390/ijms22041984 · 2021 · External reference
Preferred endocytosis of amyloid precursor protein from cholesterol-enriched lipid raft microdomains
2020 · External reference
10.1002/pro.3906
10.1002/pro.3906 · External reference
10.1016/j.bbalip.2020.158860
10.1016/j.bbalip.2020.158860 · External reference
10.1016/j.semcancer.2019.10.004
10.1016/j.semcancer.2019.10.004 · External reference
Role of ABCA7 in human health and in Alzheimer's disease
2021 · External reference
Plasma lipids as biomarkers for Alzheimer's disease: a systematic review
2020 · External reference
ABCA7 and the altered lipidostasis hypothesis of Alzheimer's disease
10.1002/alz.12220 · 2021 · External reference
10.1007/s12035-020-02211-x
10.1007/s12035-020-02211-x · External reference
10.1016/j.gene.2020.145316
10.1016/j.gene.2020.145316 · External reference
Alterations in cholesterol metabolism-related genes in sporadic Alzheimer's disease
10.1016/j.neurobiolaging.2018.01.018 · 2018 · External reference
A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration
10.3389/fpsyt.2012.00017 · 2012 · External reference
Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid-Alzheimer's disease relationships?
1801 · External reference
10.1016/s1474-4422(05)70248-9
10.1016/s1474-4422(05)70248-9 · External reference
Unresolved reference
External reference
ATP-binding cassette transporters and neurodegenerative diseases
2021 · External reference
10.3390/brainsci10020121
10.3390/brainsci10020121 · External reference
ABC transporters are key Players in Alzheimer's disease
10.3233/jad-170639 · 2018 · External reference
10.1016/j.nbd.2014.04.001
10.1016/j.nbd.2014.04.001 · External reference
10.1021/cn300077c
10.1021/cn300077c · External reference
ABC transporters and the Alzheimer's disease enigma
10.3389/fpsyt.2012.00054 · 2012 · External reference
Unresolved reference
External reference
Protective Variants in Alzheimer's Disease
10.1007/s40142-019-0156-2 · 2019 · External reference
Association of genetic variants of ABCA1 with susceptibility to dementia: (SADEM study)
10.1007/s11011-020-00577-4 · 2020 · External reference
10.2174/1567205016666190823124724
10.2174/1567205016666190823124724 · External reference
Influence of four polymorphisms in ABCA1 and PTGS2 genes on risk of Alzheimer's disease: a meta-analysis
10.1007/s10072-016-2579-9 · 2016 · External reference
ABCA7 and Pathogenic Pathways of Alzheimer's Disease
10.3390/brainsci8020027 · 2018 · External reference
Understanding the function of ABCA7 in Alzheimer's disease
10.1042/bst20150105 · 2015 · External reference
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
10.1038/ng.3246 · 2015 · External reference
Genetics of familial and sporadic Alzheimer's disease
10.2741/e605 · 2013 · External reference
10.1016/j.csbj.2021.05.018
10.1016/j.csbj.2021.05.018 · External reference
Heterogeneity of high density lipoprotein generated by ABCA1 and ABCA7
10.1194/jlr.m500092-jlr200 · 2005 · External reference
10.1016/j.atherosclerosis.2011.06.031
10.1016/j.atherosclerosis.2011.06.031 · External reference
10.1194/jlr.m600127-jlr200
10.1194/jlr.m600127-jlr200 · External reference
Acute digoxin loading reduces ABCA8A mRNA expression in the mouse liver
10.1111/j.1440-1681.2005.04301.x · 2005 · External reference
An evaluation of the mechanism of ABCA7 on cellular lipid release in ABCA7-HEC293 cell
10.3760/cma.j.issn.0366-6999.20123502 · 2013 · External reference
10.1093/bioinformatics/btab832
10.1093/bioinformatics/btab832 · External reference
C@PA: Computer-Aided Pattern Analysis to Predict Multitarget ABC Transporter Inhibitors
10.1021/acs.jmedchem.0c02199 · 2021 · External reference
Multi-target ABC transporter modulators: what next and where to go?, Future
2019 · External reference
10.1002/med.21573
10.1002/med.21573 · External reference
A benzopyrane derivative as a P-glycoprotein stimulator: a potential agent to decrease β-amyloid accumulation in Alzheimer's disease
10.1002/cmdc.201100469 · 2012 · External reference
Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1)
1859 · External reference
10.1172/jci57867
10.1172/jci57867 · External reference
Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4)
10.1124/dmd.116.069468 · 2016 · External reference
ATP sensitive potassium channel openers: A new class of ocular hypotensive agents
10.1016/j.exer.2016.06.014 · 2019 · External reference
ATP-sensitive potassium channel openers and 2,3-dimethyl-2-butylamine derivatives
10.2174/092986707779313390 · 2007 · External reference
Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives
10.2174/092986706775527947 · 2006 · External reference
SUR, ABC proteins targeted by KATP channel openers
10.1016/j.yjmcc.2004.11.030 · 2005 · External reference
Functional rescue of misfolding ABCA3 mutations by small molecular correctors
10.1093/hmg/ddy011 · 2018 · External reference
The CFTR Corrector, VX-809 (Lumacaftor), Rescues ABCA4 Trafficking Mutants: a Potential Treatment for Stargardt Disease
10.33594/000000146 · 2019 · External reference
10.1074/jbc.m115.647685
10.1074/jbc.m115.647685 · External reference
Functional defect of variants in the adenosine triphosphate-binding sites of ABCB4 and their rescue by the cystic fibrosis transmembrane conductance regulator potentiator, ivacaftor VX-770
10.1002/hep.28929 · 2017 · External reference
10.1111/liv.14518
10.1111/liv.14518 · External reference
10.1016/j.ejmech.2021.113195
10.1016/j.ejmech.2021.113195 · External reference
Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers
10.1002/cmdc.201700239 · 2017 · External reference
PET radiotracers for imaging P-glycoprotein: the challenge for early diagnosis in AD
10.1002/cmdc.201300362 · 2014 · External reference
10.1021/acs.jmedchem.5b01644
10.1021/acs.jmedchem.5b01644 · External reference
Interaction of phenothiazines, stilbenes and flavonoids with multidrug resistance-associated transporters, P-glycoprotein and MRP1
10.18388/abp.2011_2209 · 2011 · External reference
Differential effect of phenothiazines on MRP1 and P-glycoprotein activity
2009 · External reference
10.1039/c3md00196b
10.1039/c3md00196b · External reference
New purines and purine analogs as modulators of multidrug resistance
10.1021/jm960361i · 1996 · External reference
10.1002/med.21510
10.1002/med.21510 · External reference
10.1002/med.21739
10.1002/med.21739 · External reference
ABCG2/BCRP: Specific and Nonspecific Modulators
10.1002/med.21428 · 2017 · External reference
Three decades of P-gp inhibitors: skimming through several generations and scaffolds
10.2174/092986712800167392 · 2012 · External reference
Substrates and inhibitors of human multidrug resistance associated proteins and the implications in drug development
10.2174/092986708785132870 · 2008 · External reference
High-throughput flow cytometry to detect selective inhibitors of ABCB1, ABCC1, and ABCG2 transporters
10.1089/adt.2007.107 · 2008 · External reference
Early identification of clinically relevant drug interactions with the human bile salt export pump BSEP/ABCB11
10.1093/toxsci/kft197 · 2013 · External reference
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs
10.1007/s11095-009-9896-0 · 2009 · External reference
Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4
10.1038/bjp.2008.343 · 2008 · External reference
10.1074/jbc.m107041200
10.1074/jbc.m107041200 · External reference
10.1111/bjh.12246
10.1111/bjh.12246 · External reference
10.1016/j.ejmech.2017.07.062
10.1016/j.ejmech.2017.07.062 · External reference
Transport of eicosapentaenoic acid-derived PGE3, PGF(3α), and TXB3 by ABCC4
10.1371/journal.pone.0109270 · 2014 · External reference
Modulatory effects of plant phenols on human multidrug-resistance proteins 1, 4 and 5 ABCC1, 4 and 5
10.1111/j.1742-4658.2005.04888.x · 2005 · External reference
Soy Isoflavone Genistein Inhibits an Axillary Osmidrosis Risk Factor ABCC11. In Vitro Screening and Fractional Approach for ABCC11-Inhibitory Activities in Plant Extracts and Dietary Flavonoids
10.3390/nu12082452 · 2020 · External reference
A novel ATP-binding cassette transporter, ABCG6 is involved in chemoresistance of Leishmania
10.1016/j.molbiopara.2007.12.007 · 2008 · External reference
Functional analysis of ABCA8, a new drug transporter
10.1016/s0006-291x(02)02389-6 · 2002 · External reference
10.1002/1873-3468.14015
10.1002/1873-3468.14015 · External reference
Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells
10.1016/j.phymed.2019.152945 · 2019 · External reference
Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans
10.2133/dmpk.18.16 · 2003 · External reference
10.1016/s1357-2725(03)00236-x
10.1016/s1357-2725(03)00236-x · External reference
Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance
10.1016/j.bcp.2008.12.005 · 2009 · External reference
10.3390/pharmaceutics10020039
10.3390/pharmaceutics10020039 · External reference
10.1016/j.toxlet.2009.07.021
10.1016/j.toxlet.2009.07.021 · External reference
Multidrug resistance-associated proteins 3, 4, and 5
10.1007/s00424-006-0054-9 · 2007 · External reference
Tenofovir Disoproxil Fumarate Is a New Substrate of ATP-Binding Cassette Subfamily C Member 11
2017 · External reference
Unresolved reference
External reference
10.1016/j.cell.2017.05.020
10.1016/j.cell.2017.05.020 · External reference
10.1038/s41467-021-26161-7
10.1038/s41467-021-26161-7 · External reference
10.1038/s41467-021-24194-6
10.1038/s41467-021-24194-6 · External reference
10.7554/elife.63524
10.7554/elife.63524 · External reference
10.1016/j.biopha.2020.110109
10.1016/j.biopha.2020.110109 · External reference
Rational drug design of 6-substituted 4-anilino-2-phenylpyrimidines for exploration of novel ABCG2 binding site
10.1016/j.ejmech.2020.113045 · 2021 · External reference
10.1126/science.aav7102
10.1126/science.aav7102 · External reference
10.7554/elife.21829
10.7554/elife.21829 · External reference
10.1038/s41594-019-0354-3
10.1038/s41594-019-0354-3 · External reference
Mechanism of pharmacochaperoning in a mammalian K(ATP) channel revealed by cryo-EM
10.7554/elife.46417 · 2019 · External reference
10.1016/j.jmb.2021.166980
10.1016/j.jmb.2021.166980 · External reference
Study on reversal of ABCB1 mediated multidrug resistance in Colon cancer by acetogenins: An in-silico approach
2020 · External reference
The human transporter associated with antigen processing: molecular models to describe peptide binding competent states
10.1074/jbc.m112.381251 · 2012 · External reference
Identification and characterisation of putative drug binding sites in human ATP-binding cassette B5 (ABCB5) transporter, Comput Struct
2021 · External reference
Structure-guided probing of the leukotriene C(4) binding site in human multidrug resistance protein 1 (MRP1; ABCC1)
10.1096/fj.201900140r · 2019 · External reference
Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics
10.3390/molecules26041051 · 2021 · External reference
Mutagenic Analysis of the Putative ABCC6 Substrate-Binding Cavity Using a New Homology Model
10.3390/ijms22136910 · 2021 · External reference
10.1085/jgp.201912360
10.1085/jgp.201912360 · External reference
Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2'-deoxyuridine-5'-monophosphate on ABCC11 in silico models
10.1186/1472-6807-13-7 · 2013 · External reference
10.1006/bbrc.2000.2954
10.1006/bbrc.2000.2954 · External reference
10.22541/au.162040347.71324039/v1
10.22541/au.162040347.71324039/v1 · External reference
10.1038/nature17666
10.1038/nature17666 · External reference
Unresolved reference
2019 · External reference
The motor domains of ABC-transporters. What can structures tell us?
10.1007/s00210-005-0031-4 · 2006 · External reference
Affinity, specificity, diversity: a challenge for the ABC transporter TAP in cellular immunity
10.1002/1439-7633(20000703)1:1<16::aid-cbic16>3.0.co;2-y · 2000 · External reference
10.1074/jbc.m204996200
10.1074/jbc.m204996200 · External reference
10.1002/pro.3960
10.1002/pro.3960 · External reference
10.1038/s41422-020-0302-0
10.1038/s41422-020-0302-0 · External reference
10.1016/j.cell.2017.02.024
10.1016/j.cell.2017.02.024 · External reference
Cryo-EM structure of ABCG5/G8 in complex with modulating antibodies
10.1038/s42003-021-02039-8 · 2021 · External reference
Cryo-EM structure of human ABCB8 transporter in nucleotide binding state
10.1016/j.bbrc.2021.04.007 · 2021 · External reference
10.1073/pnas.1217042110
10.1073/pnas.1217042110 · External reference
10.1038/s41422-019-0222-z
10.1038/s41422-019-0222-z · External reference
pso@autodock: a fast flexible molecular docking program based on Swarm intelligence
10.1111/j.1747-0285.2007.00588.x · 2007 · External reference
Water-soluble inhibitors of ABCG2 (BCRP) - A fragment-based and computational approach
10.1016/j.ejmech.2020.112958 · 2021 · External reference
Superior Pyrimidine Derivatives as Selective ABCG2 Inhibitors and Broad-Spectrum ABCB1, ABCC1, and ABCG2 Antagonists
10.1021/acs.jmedchem.0c00961 · 2020 · External reference
10.1016/j.ejmech.2019.111655
10.1016/j.ejmech.2019.111655 · External reference
10.1021/acs.jmedchem.8b01821
10.1021/acs.jmedchem.8b01821 · External reference
10.1021/acs.jmedchem.7b00788
10.1021/acs.jmedchem.7b00788 · External reference
10.1016/j.ejmech.2017.08.020
10.1016/j.ejmech.2017.08.020 · External reference
10.1021/acs.jmedchem.6b00330
10.1021/acs.jmedchem.6b00330 · External reference
Thieno[2,3-b]pyridines–a new class of multidrug resistance (MDR) modulators
10.1016/j.bmc.2014.09.023 · 2014 · External reference
Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2
10.1016/j.ejmech.2013.06.035 · 2013 · External reference
Multi-drug-resistance-reverting agents: 2-aryloxazole and 2-arylthiazole derivatives as potent BCRP or MRP1 inhibitors
10.1002/cmdc.200800329 · 2009 · External reference
Bicalutamide failure in prostate cancer treatment: involvement of Multi Drug Resistance proteins
10.1016/j.ejphar.2008.10.038 · 2008 · External reference
10.1021/jm030644s
10.1021/jm030644s · External reference
10.1021/jm0306430
10.1021/jm0306430 · External reference
Unresolved reference
External reference
Compound dataset and custom code for deep generative multi-target compound design
10.2144/fsoa-2021-0033 · 2021 · External reference
Unresolved reference
External reference
10.4155/fdd-2020-0014
10.4155/fdd-2020-0014 · External reference
Cyclosporine A and PSC833 inhibit ABCA1 function via direct binding
1831 · External reference
Probucol inactivates ABCA1 in the plasma membrane with respect to its mediation of apolipoprotein binding and high density lipoprotein assembly and to its proteolytic degradation
10.1074/jbc.m403765200 · 2004 · External reference
Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1
10.1182/blood.v90.8.2911 · 1997 · External reference
10.1074/jbc.272.5.2695
10.1074/jbc.272.5.2695 · External reference
Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
10.3390/pharmaceutics13010081 · 2021 · External reference
10.3390/cancers12040813
10.3390/cancers12040813 · External reference
10.1096/fj.00-0798com
10.1096/fj.00-0798com · External reference
10.3390/molecules22040600
10.3390/molecules22040600 · External reference
Identification of N-benzothiazolyl-2-benzenesulfonamides as novel ABCA1 expression upregulators
10.1039/c9md00556k · 2020 · External reference
10.1194/jlr.d018051
10.1194/jlr.d018051 · External reference
10.1093/nar/gkh131
10.1093/nar/gkh131 · External reference
10.1093/nar/28.1.235
10.1093/nar/28.1.235 · External reference
How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules?
10.1002/1096-987x(200009)21:12<1049::aid-jcc3>3.0.co;2-f · 2000 · External reference
10.1002/jcc.21256
10.1002/jcc.21256 · External reference
10.1021/acs.jctc.5b00864
10.1021/acs.jctc.5b00864 · External reference
